drugset / Trial / NCT05541315
A Single Ascending Dose Study of JNJ-88260237 in Healthy Participants
RandomizedSequentialDouble-blindOther
Summary
The purpose of this study is to assess the safety and tolerability of a single oral dose of JNJ-88260237 in healthy participants
Timeline
- Start
- 2022-09-14
- Primary completion
- 2023-05-09
- Completion
- 2023-05-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JNJ-88260237 | Unknown | — | Oral |
Indications
No indication recorded.